- Home
- NRSN vs WVVI Comparison
NRSN vs WVVI Comparison
Compare NRSN & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- WVVI
- Stock Information
- Founded
- NRSN 2017
- WVVI 1983
- Country
- NRSN Israel
- WVVI United States
- Employees
- NRSN N/A
- WVVI N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- NRSN Health Care
- WVVI Consumer Staples
- Exchange
- NRSN Nasdaq
- WVVI Nasdaq
- Market Cap
- NRSN 26.0M
- WVVI 29.8M
- IPO Year
- NRSN 2021
- WVVI N/A
- Fundamental
- Price
- NRSN $0.91
- WVVI $6.19
- Analyst Decision
- NRSN Hold
- WVVI
- Analyst Count
- NRSN 1
- WVVI 0
- Target Price
- NRSN N/A
- WVVI N/A
- AVG Volume (30 Days)
- NRSN 172.3K
- WVVI 7.9K
- Earning Date
- NRSN 04-08-2025
- WVVI 03-25-2025
- Dividend Yield
- NRSN N/A
- WVVI N/A
- EPS Growth
- NRSN N/A
- WVVI N/A
- EPS
- NRSN N/A
- WVVI N/A
- Revenue
- NRSN N/A
- WVVI $39,782,442.00
- Revenue This Year
- NRSN N/A
- WVVI N/A
- Revenue Next Year
- NRSN N/A
- WVVI N/A
- P/E Ratio
- NRSN N/A
- WVVI N/A
- Revenue Growth
- NRSN N/A
- WVVI 1.65
- 52 Week Low
- NRSN $0.51
- WVVI $3.17
- 52 Week High
- NRSN $2.25
- WVVI $6.33
- Technical
- Relative Strength Index (RSI)
- NRSN 29.02
- WVVI 58.15
- Support Level
- NRSN $1.00
- WVVI $5.75
- Resistance Level
- NRSN $1.13
- WVVI $6.19
- Average True Range (ATR)
- NRSN 0.08
- WVVI 0.23
- MACD
- NRSN -0.02
- WVVI -0.02
- Stochastic Oscillator
- NRSN 8.23
- WVVI 85.73
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.